2018年12月，集团公司通过对盐城市滨海医药产业园的综合考察决定正式入驻盐城市滨海医药产业园，成立江苏欧歌制药有限公司，从此开启成品药研制的新篇章。得益于集团公司雄厚的科研基础欧歌产品选型均为市场前景看好，产品附加值高的品种，涵盖心血管治疗、癫痫治疗、抗乙肝病毒、抗艾滋病毒、抗肿瘤治疗等多个领域，计划年产量为口服片剂2亿片，胶囊剂5000万片，口服液5000万支，冻干粉针5000万支，小容量注射剂5000万支，面向国内市场以及美洲、欧洲、日本、韩国、印度等多个国外市场。欧歌制药的成功投产将标志着阿尔法药业集团医药中间体-原料药-成品药全产业链的形成，同时也是集团公司发展自主品牌，向国内，国际闻名的制药企业迈出扎实的步。
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
